Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Rangering i aksjer #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Aksjekurs
$0.0416118
Markedsverdi
$32.25M
Endring (1 dag)
-1.67%
Endring (1 år)
-59.58%
Land
AU
Handel Neurizon Therapeutics Limited (NUZ)

Kategori

Aksjeprishistorikk for Neurizon Therapeutics Limited (NUZ)
Høyeste sluttskurs: $0.04 den 2026-08-01

Laveste sluttskurs: $3.11 den 2001-10-01
Aksjeprishistorikk for Neurizon Therapeutics Limited fra 2001 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -8.62%
2025 -37.70%
2024 50.11%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.01 6.64%
CH